College of Nursing Pair Present at Apple Nursing Leadership Event

Greer Glazer, PhD, dean of the University of Cincinnati (UC) College of Nursing, and Matt Rota, director of the Center for Academic Technology, Education Resources and Instructional Design in the College of Nursing, are taking part as guest speakers and panel participants at the Preparing Nursing Students for Success in a Mobile Workforce event hosted by Apple. The event will be held on Wednesday, March 22, 2017 at the Apple Executive Briefing Center in Reston, Virginia. 

Apple is hosting leadership from colleges of nursing and will facilitate an in-depth conversation to discover how faculty and students in nursing programs are using mobile devices and digital learning experiences to communicate, create, collaborate and innovate.

"We feel that your college is a ‘lighthouse’ in nursing education which has demonstrated tremendous leadership and commitment to innovation with your iCoN program,” wrote Jason Beckham, health market executive for Apple Education in the invitation to Glazer and Rota.

The UC College of Nursing has twice been designated as an Apple Distinguished Program, and is home to the iCoN initiative, which is the innovation of nursing education through the creative leveraging of iPads. 

Related Stories

1

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.

3

Study: Additional radiation for liver cancer does not increase toxicity

March 10, 2026

New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.